In this Bio-IT World session we explore how ConcertAI—a leading oncology-focused AI technology company—is accelerating clinical trials and research through its proprietary platform, CARA.ai Powered by advanced generative AI, CARA integrates ConcertAI’s proprietary AI solutions with AWS Cloud and NVIDIA microservices, including NIM and BioNeMo, to enable a scalable, multi-agent framework development. CARAai supports the processing of large-scale clinical data, management of predictive models, and rapid product development. By leveraging NVIDIA’s tools on AWS infrastructure, ConcertAI efficiently builds comprehensive knowledge graphs and develops applications that address critical components of clinical solution development—from optimizing eligibility criteria and site strategy to improving patient matching, enrolment forecasting, and trial execution.